Data / Form D filings / Euphrates Vascular, Inc.
Euphrates Vascular, Inc.: Form D filings
Euphrates Vascular, Inc., a biotechnology company in St. Louis, MO, filed 3 Form D notices with the SEC between 2018 and 2023. The latest, on October 3, 2023, reports $9.1 million sold of a $9.1 million offering to 33 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 8460 Watson Road, Suite 112, St. Louis, MO, 63119
- Phone
- (518) 944-3367
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2018
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1752992
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 3, 2023 | Amendment | $9,084,802 | $9,084,802 | 33 | Jul 15, 2020 | sec.gov | |
| Jun 1, 2021 | New notice | $7,206,980 | $5,984,167 | $1,222,813 | 25 | Jul 15, 2020 | sec.gov |
| Sep 17, 2018 | New notice | $4,000,000 | $590,000 | $3,410,000 | 4 | Aug 31, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cathy Omid Matthes | Executive Officer | |
| Martin Omid Akhavan | Executive Officer, Director | |
| Sean Morris | Director |
Every Form D from the week of Oct 2, 2023 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Euphrates Vascular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.